AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...

AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...

The Bill & Melinda Gates Foundation, Novo Nordisk Foundation, and Wellcome are collaborating on a $50 million effort to boost ...

Researchers have used artificial intelligence to identify 25 new protein compounds that can kill bacteria and fungi, ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

The winter flu season features two types of influenza. Here's what you need to know about them and how they differ.

In 2022, chronic lower respiratory disease was the sixth highest cause of death in the U.S., according to results published ...

In an update on Oropouche virus activity, the Pan American Health Organization (PAHO) yesterday said in the first four weeks ...

Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment ...

A series of reports released today by the European Centre for Disease Prevention and Control (ECDC) show sexually transmitted ...

The New Hampshire Department of Health and Human Services (DHHS) said a person from Merrimack County has become the first ...

Aug. 6, 2024 — An AI-based analysis of over 2 million hospital visits has found that most of the time, a pneumonia diagnosis made in the hospital will change from a patient's entrance to their ...